La brochure »Les aimants« de STORZ MEDICAL

Magnets

Le magnétisme est une force motrice centrale dans le monde d'aujourd'hui dominé par la technologie - que ce soit sur route ou sur rail, dans les hôpitaux ou dans les ménages privés. Voici un cours accéléré sur tout ce que vous devez savoir sur les merveilles du magnétisme et son énorme potentiel en médecine. Bonne lecture.

Les professionnels de santé peuvent commander un exemplaire gratuit de la brochure à l'adresse e-mail suivante: .

Lire la suite
0
  15 lectures
  0 commentaires
15 lectures
0 commentaires

Thérapie extracorporelle par transduction magnétique (EMTT): MAGNETOLITH DE STORZ MEDICAL reçoit l'autorisation de la FDA pour 510 (k)

MAGNETOLITH_002

Le 3 mai 2021, STORZ MEDICAL a reçu l'autorisation de la Food and Drug Administration (FDA) des États-Unis pour 510 (k) pour le MAGNETOLITH®. L'appareil thérapeutique est désormais autorisé aux États-Unis (en tant que dispositif médical de classe II) pour les indications suivantes :

  • Relaxation des spasmes musculaires
  • Prévention ou retard de l'amyotrophie
  • Augmentation de la circulation sanguine locale
  • Rééducation musculaire
  • Stimulation post-chirurgicale immédiate des muscles du mollet pour prévenir la thrombose veineuse
  • Maintien ou augmentation de l'amplitude des mouvements
Lire la suite
0
  169 lectures
  0 commentaires
Mots-clés :
169 lectures
0 commentaires

100 devices in 7 months: STORZ MEDICAL has successfully launched MAGNETOLITH

2020-10-13_news_Magnetolith_Dr_Goerner

In September 2020, the 100th MAGNETOLITH® was ordered and delivered to Dr Damian Görner from the Steglitz Spine and Joints Centre in Berlin. In an interview, the specialist for orthopaedics and trauma surgery explains why he decided to use MAGNETOLITH®, which indications he treats and how EMTT® and ESWT complement each other.

Lire la suite
0
  1796 lectures
  0 commentaires
1796 lectures
0 commentaires

STORZ MEDICAL’s MAGNETOLITH receives CE approval

2020-02-24_001_news

In February 2020, STORZ MEDICAL has received the CE approval for the MAGNETOLITH® system, which is the successor of the CELLACTOR® MT1. Extracorporeal Magnetotransduction Therapy (EMTT®) with the MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or Achilles tendon. The non-invasive, outpatient therapy is virtually free of side effects.

Lire la suite
2
  5320 lectures
  0 commentaires
5320 lectures
0 commentaires

MEDICA 2019: STORZ MEDICAL presents new innovations NEUROLITH, MAGNETOLITH and redesigned MODULITH SLC

2019-11-26_news_MEDICA

Düsseldorf/Germany: After three fascinating and very interesting days, MEDICA 2019 ended on 21 November. Once again, the world’s leading medical trade fair was a huge success. At STORZ MEDICAL’s exhibition stand in hall 10, the full range of the company’s therapy options was on display – including several innovations. Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system, a unique procedure for patients with Alzheimer's disease, was explained in detail by Dr Rafael Storz, who also answered the visitors’ questions. In addition, the new MAGNETOLITH® for Extracorporeal Magnetotransduction Therapy (EMTT®) and the redesigned MODULITH® SLC were also at the centre of attention. Both devices were unveiled and presented during the trade fair.

Lire la suite
1
  5374 lectures
  0 commentaires
5374 lectures
0 commentaires
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel